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Introduction
Behçet’s disease (BD) is rare in childhood and remains
challenging in diagnosis and lack of evidence-based data
for its treatment. Hence there is an urgent need to
understand the scope of the disease in children.
Objectives
The aim of this study is to describe the clinical spectrum
and the therapies used to treat children with Behçet’s dis-
ease (BD) in children.
Methods
46 patients (22 male) were identified with a positive
family history of BD in 6 cases. Age of onset was 4.87
(0.04-15.71) years with a time to diagnosis of 3.74 (0.25-
13.48) years. The main clinical features at presentation
were: recurrent oral ulceration (87%), genital ulceration
(20%), cutaneous symptoms (11%), fever (30%), gastroin-
testinal symptoms (26%), musculoskeletal (22%). uveitis
(2%). Recurrent genital ulceration was significantly more
common in female patients (P = 0.044). The majority of
children were treated with colchicine (74%) and corticos-
teroid (41%). Anti TNF-a treatment was reserved for
severe and/or refractory cases (15%). There was a median
of 2 (range 0-12) episodes of oral ulceration per year
after the treatment. Interestingly only 10 patients fulfilled
The International Study Group (ISG) BD diagnostic
criteria.
Results
46 patients (22 male) were identified with a positive
family history of BD in 6 cases. Age of onset was 4.87
(0.04-15.71) years with a time to diagnosis of 3.74 (0.25-
13.48) years. The main clinical features at presentation
were: recurrent oral ulceration (87%), genital ulceration
(20%), cutaneous symptoms (11%), fever (30%), gastroin-
testinal symptoms (26%), musculoskeletal (22%). uveitis
(2%). Recurrent genital ulceration was significantly more
common in female patients (P = 0.044). The majority of
children were treated with colchicine (74%) and corti-
costeroid (41%). Anti TNF-a treatment was reserved for
severe and/or refractory cases (15%). There was a
median of 2 (range 0-12) episodes of oral ulceration per
year after the treatment. Interestingly only 10 patients
fulfilled The International Study Group (ISG) BD
diagnostic criteria.
Conclusion
Although most cases were diagnosed in late childhood
the first presentation was as early as 1 month old. Delay
in diagnosis due to incomplete presentation in certain
cases. Oral ulceration was the most common presenting
symptom. Uveitis was less frequent than previous series.
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